Ion Asset Management Ltd. Rigel Pharmaceuticals Inc Transaction History

Ion Asset Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $7.87 Million - $11.9 Million	-3,335,240 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $505,127 - $649,449	-144,322 Reduced 4.15%	3,335,240 $12.1 Million
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $471,441 - $692,667	-152,570 Reduced 4.2%	3,479,562 $15.1 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $6.04 Million - $8.88 Million	1,802,132 Added 98.48%	3,632,132 $12.4 Million
Q4 2020 Feb 17, 2021	BUY	$2.35 - $3.74 $4.3 Million - $6.84 Million	1,830,000 New	1,830,000 $6.41 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.95B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Ion Asset Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Ion Asset Management Ltd. with notifications on news.